Carlos Cruchaga

Washington University School of Medicine, St. Louis, MO, United States 
Alzheimer's, genetics, genomics, quantitative traits, WES, WGS, proteomics
"Carlos Cruchaga"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gonneaud J, Baria AT, Pichet Binette A, et al. (2021) Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature Communications. 12: 5346
Li F, Eteleeb A, Buchser W, et al. (2021) Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's disease. Biorxiv : the Preprint Server For Biology
Ibanez L, Cruchaga C, Fernández MV. (2021) Advances in Genetic and Molecular Understanding of Alzheimer's Disease. Genes. 12
Sun YV, Li C, Hui Q, et al. (2021) A Multi-center Genome-wide Association Study of Cervical Dystonia. Movement Disorders : Official Journal of the Movement Disorder Society
Chen CD, Joseph-Mathurin N, Sinha N, et al. (2021) Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. Acta Neuropathologica
Muiño E, Cárcel-Márquez J, Carrera C, et al. (2021) Genetic Variation Is Associated with Post-Reperfusion Therapy Parenchymal Hematoma. A GWAS Meta-Analysis. Journal of Clinical Medicine. 10
Yang C, Farias FHG, Ibanez L, et al. (2021) Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nature Neuroscience
Salloway S, Farlow M, McDade E, et al. (2021) A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine
Harrington KD, Aschenbrenner AJ, Maruff P, et al. (2021) Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older Adults. Psychological Science. 956797620985518
Damotte V, van der Lee SJ, Chouraki V, et al. (2021) Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
See more...